SCHEMBL20816036

SCHEMBL20816036

CCc1ccc(S(=O)(=O)n2cc(/C=C/C(=O)OCc3ccc(F)cc3)cc2C(=O)OC)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 2/20 0.43
▸ POLB P06746 2/20 0.40
▸ HDAC3 O15379 1/20 0.40
▸ HDAC4 P56524 1/20 0.40
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC7 Q8WUI4 1/20 0.40
▸ HDAC2 Q92769 1/20 0.40
▸ HDAC10 Q969S8 1/20 0.40
▸ HDAC11 Q96DB2 1/20 0.40
▸ HDAC8 Q9BY41 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ HDAC9 Q9UKV0 1/20 0.40
▸ HDAC5 Q9UQL6 1/20 0.40
▸ GPR183 P32249 1/20 0.39
▸ CNR1 P21554 1/20 0.38
▸ CNR2 P34972 1/20 0.38
▸ LMNA P02545 2/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ NOS3 P29474 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20816045 0.83 LMNA (0.47) METPOLBLMNANOS2MAPT
SCHEMBL20816043 0.70 OPRM1 (0.47) LMNANPC1RAB9AMAPTKMT2A
SCHEMBL12393140 0.68 KDM4E (0.46) POLBHDAC3HDAC4HDAC1HDAC7
SCHEMBL20816037 0.67 PTGS2 (0.42) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL22300409 0.66 MEN1 (0.50) POLBHDAC3HDAC4HDAC1HDAC7
SCHEMBL1156585 0.65 FBP1 (0.45) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL2134855 0.64 CA2 (0.48) GPR183LMNAKMT2ANOD2NOD1
SCHEMBL10125216 0.64 POLB (0.45) POLBLMNAGAAMAPTKMT2A
SCHEMBL9414075 0.62 CA12 (0.66) METHDAC3HDAC1HDAC2HDAC8
SCHEMBL9414072 0.62 CA12 (0.66) METHDAC3HDAC1HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10577371-B2 Small molecule histone methyltransferase SUV39H1 inhibitor and uses thereof AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC. (US) 2020-03-03 — — US disclosed
US-20190084987-A1 Small Molecule Histone Methyltransferase SUV39H1 Inhibitor and Uses Thereof NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2019-03-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10577371-B2 Small molecule histone methyltransferase SUV39H1 inhibitor and uses thereof SUV39H2, SUV39H1, EZH1 MET 1681/4885POLB 1730/4885HDAC3 79/4885
US-20190084987-A1 Small Molecule Histone Methyltransferase SUV39H1 Inhibitor and Uses Thereof SUV39H2, SUV39H1, EZH1 MET 1681/4885POLB 1730/4885HDAC3 79/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback